The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prokaryotic Recombinant Protein Market Research Report 2025
Synopsis
Prokaryotic recombinant proteins are proteins that are encrypted by genes (recombinant DNA) and cloned into the prokaryotic system (E. coli). The high specificity and low immunogenicity of prokaryotic recombinant proteins make them suitable for chronic therapy and several autoimmune diseases.
The global Prokaryotic Recombinant Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prokaryotic Recombinant Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prokaryotic Recombinant Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prokaryotic Recombinant Protein include Eli Lilly and Company, Merck, Roche, Prospec-Tany Technogene, Cusabio Technology, Randox Laboratories, Batavia Biosciences, Geno Technology and Kaneka and Eurogentec, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prokaryotic Recombinant Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prokaryotic Recombinant Protein.
Report Scope
The Prokaryotic Recombinant Protein market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prokaryotic Recombinant Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prokaryotic Recombinant Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Merck
Roche
Prospec-Tany Technogene
Cusabio Technology
Randox Laboratories
Batavia Biosciences
Geno Technology
Kaneka and Eurogentec
Abnova Corporation
Cayman Chemical Company
Geltor IndieBio
Bioclone
Segment by Type
Hormones
Interferons
Interleukins
Others
Segment by Application
Biotechnology Companies
Research institutes
Contract Research organizations
Hospital
Laboratories
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prokaryotic Recombinant Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prokaryotic Recombinant Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Prokaryotic recombinant proteins are proteins that are encrypted by genes (recombinant DNA) and cloned into the prokaryotic system (E. coli). The high specificity and low immunogenicity of prokaryotic recombinant proteins make them suitable for chronic therapy and several autoimmune diseases.
The global Prokaryotic Recombinant Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prokaryotic Recombinant Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prokaryotic Recombinant Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prokaryotic Recombinant Protein include Eli Lilly and Company, Merck, Roche, Prospec-Tany Technogene, Cusabio Technology, Randox Laboratories, Batavia Biosciences, Geno Technology and Kaneka and Eurogentec, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prokaryotic Recombinant Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prokaryotic Recombinant Protein.
Report Scope
The Prokaryotic Recombinant Protein market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prokaryotic Recombinant Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prokaryotic Recombinant Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Merck
Roche
Prospec-Tany Technogene
Cusabio Technology
Randox Laboratories
Batavia Biosciences
Geno Technology
Kaneka and Eurogentec
Abnova Corporation
Cayman Chemical Company
Geltor IndieBio
Bioclone
Segment by Type
Hormones
Interferons
Interleukins
Others
Segment by Application
Biotechnology Companies
Research institutes
Contract Research organizations
Hospital
Laboratories
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prokaryotic Recombinant Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prokaryotic Recombinant Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prokaryotic Recombinant Protein Market Overview
1.1 Product Overview and Scope of Prokaryotic Recombinant Protein
1.2 Prokaryotic Recombinant Protein Segment by Type
1.2.1 Global Prokaryotic Recombinant Protein Market Value Comparison by Type (2024-2030)
1.2.2 Hormones
1.2.3 Interferons
1.2.4 Interleukins
1.2.5 Others
1.3 Prokaryotic Recombinant Protein Segment by Application
1.3.1 Global Prokaryotic Recombinant Protein Market Value by Application: (2024-2030)
1.3.2 Biotechnology Companies
1.3.3 Research institutes
1.3.4 Contract Research organizations
1.3.5 Hospital
1.3.6 Laboratories
1.3.7 Others
1.4 Global Prokaryotic Recombinant Protein Market Size Estimates and Forecasts
1.4.1 Global Prokaryotic Recombinant Protein Revenue 2019-2030
1.4.2 Global Prokaryotic Recombinant Protein Sales 2019-2030
1.4.3 Global Prokaryotic Recombinant Protein Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prokaryotic Recombinant Protein Market Competition by Manufacturers
2.1 Global Prokaryotic Recombinant Protein Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prokaryotic Recombinant Protein Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prokaryotic Recombinant Protein Average Price by Manufacturers (2019-2024)
2.4 Global Prokaryotic Recombinant Protein Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prokaryotic Recombinant Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prokaryotic Recombinant Protein, Product Type & Application
2.7 Prokaryotic Recombinant Protein Market Competitive Situation and Trends
2.7.1 Prokaryotic Recombinant Protein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prokaryotic Recombinant Protein Players Market Share by Revenue
2.7.3 Global Prokaryotic Recombinant Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prokaryotic Recombinant Protein Retrospective Market Scenario by Region
3.1 Global Prokaryotic Recombinant Protein Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prokaryotic Recombinant Protein Global Prokaryotic Recombinant Protein Sales by Region: 2019-2030
3.2.1 Global Prokaryotic Recombinant Protein Sales by Region: 2019-2024
3.2.2 Global Prokaryotic Recombinant Protein Sales by Region: 2025-2030
3.3 Global Prokaryotic Recombinant Protein Global Prokaryotic Recombinant Protein Revenue by Region: 2019-2030
3.3.1 Global Prokaryotic Recombinant Protein Revenue by Region: 2019-2024
3.3.2 Global Prokaryotic Recombinant Protein Revenue by Region: 2025-2030
3.4 North America Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.4.1 North America Prokaryotic Recombinant Protein Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prokaryotic Recombinant Protein Sales by Country (2019-2030)
3.4.3 North America Prokaryotic Recombinant Protein Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.5.1 Europe Prokaryotic Recombinant Protein Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prokaryotic Recombinant Protein Sales by Country (2019-2030)
3.5.3 Europe Prokaryotic Recombinant Protein Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.6.1 Asia Pacific Prokaryotic Recombinant Protein Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prokaryotic Recombinant Protein Sales by Country (2019-2030)
3.6.3 Asia Pacific Prokaryotic Recombinant Protein Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.7.1 Latin America Prokaryotic Recombinant Protein Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prokaryotic Recombinant Protein Sales by Country (2019-2030)
3.7.3 Latin America Prokaryotic Recombinant Protein Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa Prokaryotic Recombinant Protein Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prokaryotic Recombinant Protein Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prokaryotic Recombinant Protein Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prokaryotic Recombinant Protein Sales by Type (2019-2030)
4.1.1 Global Prokaryotic Recombinant Protein Sales by Type (2019-2024)
4.1.2 Global Prokaryotic Recombinant Protein Sales by Type (2025-2030)
4.1.3 Global Prokaryotic Recombinant Protein Sales Market Share by Type (2019-2030)
4.2 Global Prokaryotic Recombinant Protein Revenue by Type (2019-2030)
4.2.1 Global Prokaryotic Recombinant Protein Revenue by Type (2019-2024)
4.2.2 Global Prokaryotic Recombinant Protein Revenue by Type (2025-2030)
4.2.3 Global Prokaryotic Recombinant Protein Revenue Market Share by Type (2019-2030)
4.3 Global Prokaryotic Recombinant Protein Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prokaryotic Recombinant Protein Sales by Application (2019-2030)
5.1.1 Global Prokaryotic Recombinant Protein Sales by Application (2019-2024)
5.1.2 Global Prokaryotic Recombinant Protein Sales by Application (2025-2030)
5.1.3 Global Prokaryotic Recombinant Protein Sales Market Share by Application (2019-2030)
5.2 Global Prokaryotic Recombinant Protein Revenue by Application (2019-2030)
5.2.1 Global Prokaryotic Recombinant Protein Revenue by Application (2019-2024)
5.2.2 Global Prokaryotic Recombinant Protein Revenue by Application (2025-2030)
5.2.3 Global Prokaryotic Recombinant Protein Revenue Market Share by Application (2019-2030)
5.3 Global Prokaryotic Recombinant Protein Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Corporation Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly and Company Prokaryotic Recombinant Protein Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Prokaryotic Recombinant Protein Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Prokaryotic Recombinant Protein Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Prospec-Tany Technogene
6.4.1 Prospec-Tany Technogene Corporation Information
6.4.2 Prospec-Tany Technogene Description and Business Overview
6.4.3 Prospec-Tany Technogene Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prospec-Tany Technogene Prokaryotic Recombinant Protein Product Portfolio
6.4.5 Prospec-Tany Technogene Recent Developments/Updates
6.5 Cusabio Technology
6.5.1 Cusabio Technology Corporation Information
6.5.2 Cusabio Technology Description and Business Overview
6.5.3 Cusabio Technology Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cusabio Technology Prokaryotic Recombinant Protein Product Portfolio
6.5.5 Cusabio Technology Recent Developments/Updates
6.6 Randox Laboratories
6.6.1 Randox Laboratories Corporation Information
6.6.2 Randox Laboratories Description and Business Overview
6.6.3 Randox Laboratories Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Randox Laboratories Prokaryotic Recombinant Protein Product Portfolio
6.6.5 Randox Laboratories Recent Developments/Updates
6.7 Batavia Biosciences
6.6.1 Batavia Biosciences Corporation Information
6.6.2 Batavia Biosciences Description and Business Overview
6.6.3 Batavia Biosciences Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Batavia Biosciences Prokaryotic Recombinant Protein Product Portfolio
6.7.5 Batavia Biosciences Recent Developments/Updates
6.8 Geno Technology
6.8.1 Geno Technology Corporation Information
6.8.2 Geno Technology Description and Business Overview
6.8.3 Geno Technology Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Geno Technology Prokaryotic Recombinant Protein Product Portfolio
6.8.5 Geno Technology Recent Developments/Updates
6.9 Kaneka and Eurogentec
6.9.1 Kaneka and Eurogentec Corporation Information
6.9.2 Kaneka and Eurogentec Description and Business Overview
6.9.3 Kaneka and Eurogentec Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kaneka and Eurogentec Prokaryotic Recombinant Protein Product Portfolio
6.9.5 Kaneka and Eurogentec Recent Developments/Updates
6.10 Abnova Corporation
6.10.1 Abnova Corporation Corporation Information
6.10.2 Abnova Corporation Description and Business Overview
6.10.3 Abnova Corporation Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Abnova Corporation Prokaryotic Recombinant Protein Product Portfolio
6.10.5 Abnova Corporation Recent Developments/Updates
6.11 Cayman Chemical Company
6.11.1 Cayman Chemical Company Corporation Information
6.11.2 Cayman Chemical Company Prokaryotic Recombinant Protein Description and Business Overview
6.11.3 Cayman Chemical Company Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cayman Chemical Company Prokaryotic Recombinant Protein Product Portfolio
6.11.5 Cayman Chemical Company Recent Developments/Updates
6.12 Geltor IndieBio
6.12.1 Geltor IndieBio Corporation Information
6.12.2 Geltor IndieBio Prokaryotic Recombinant Protein Description and Business Overview
6.12.3 Geltor IndieBio Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Geltor IndieBio Prokaryotic Recombinant Protein Product Portfolio
6.12.5 Geltor IndieBio Recent Developments/Updates
6.13 Bioclone
6.13.1 Bioclone Corporation Information
6.13.2 Bioclone Prokaryotic Recombinant Protein Description and Business Overview
6.13.3 Bioclone Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Bioclone Prokaryotic Recombinant Protein Product Portfolio
6.13.5 Bioclone Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prokaryotic Recombinant Protein Industry Chain Analysis
7.2 Prokaryotic Recombinant Protein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prokaryotic Recombinant Protein Production Mode & Process
7.4 Prokaryotic Recombinant Protein Sales and Marketing
7.4.1 Prokaryotic Recombinant Protein Sales Channels
7.4.2 Prokaryotic Recombinant Protein Distributors
7.5 Prokaryotic Recombinant Protein Customers
8 Prokaryotic Recombinant Protein Market Dynamics
8.1 Prokaryotic Recombinant Protein Industry Trends
8.2 Prokaryotic Recombinant Protein Market Drivers
8.3 Prokaryotic Recombinant Protein Market Challenges
8.4 Prokaryotic Recombinant Protein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Prokaryotic Recombinant Protein Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Prokaryotic Recombinant Protein Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Prokaryotic Recombinant Protein Market Competitive Situation by Manufacturers in 2023
Table 4. Global Prokaryotic Recombinant Protein Sales (Kg) of Key Manufacturers (2019-2024)
Table 5. Global Prokaryotic Recombinant Protein Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Prokaryotic Recombinant Protein Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Prokaryotic Recombinant Protein Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Prokaryotic Recombinant Protein Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Prokaryotic Recombinant Protein, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Prokaryotic Recombinant Protein, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prokaryotic Recombinant Protein, Product Type & Application
Table 12. Global Key Manufacturers of Prokaryotic Recombinant Protein, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prokaryotic Recombinant Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prokaryotic Recombinant Protein as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prokaryotic Recombinant Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Prokaryotic Recombinant Protein Sales by Region (2019-2024) & (Kg)
Table 18. Global Prokaryotic Recombinant Protein Sales Market Share by Region (2019-2024)
Table 19. Global Prokaryotic Recombinant Protein Sales by Region (2025-2030) & (Kg)
Table 20. Global Prokaryotic Recombinant Protein Sales Market Share by Region (2025-2030)
Table 21. Global Prokaryotic Recombinant Protein Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Prokaryotic Recombinant Protein Revenue Market Share by Region (2019-2024)
Table 23. Global Prokaryotic Recombinant Protein Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Prokaryotic Recombinant Protein Revenue Market Share by Region (2025-2030)
Table 25. North America Prokaryotic Recombinant Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Prokaryotic Recombinant Protein Sales by Country (2019-2024) & (Kg)
Table 27. North America Prokaryotic Recombinant Protein Sales by Country (2025-2030) & (Kg)
Table 28. North America Prokaryotic Recombinant Protein Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Prokaryotic Recombinant Protein Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Prokaryotic Recombinant Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Prokaryotic Recombinant Protein Sales by Country (2019-2024) & (Kg)
Table 32. Europe Prokaryotic Recombinant Protein Sales by Country (2025-2030) & (Kg)
Table 33. Europe Prokaryotic Recombinant Protein Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Prokaryotic Recombinant Protein Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Prokaryotic Recombinant Protein Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Prokaryotic Recombinant Protein Sales by Region (2019-2024) & (Kg)
Table 37. Asia Pacific Prokaryotic Recombinant Protein Sales by Region (2025-2030) & (Kg)
Table 38. Asia Pacific Prokaryotic Recombinant Protein Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Prokaryotic Recombinant Protein Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Prokaryotic Recombinant Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Prokaryotic Recombinant Protein Sales by Country (2019-2024) & (Kg)
Table 42. Latin America Prokaryotic Recombinant Protein Sales by Country (2025-2030) & (Kg)
Table 43. Latin America Prokaryotic Recombinant Protein Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Prokaryotic Recombinant Protein Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Prokaryotic Recombinant Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Prokaryotic Recombinant Protein Sales by Country (2019-2024) & (Kg)
Table 47. Middle East & Africa Prokaryotic Recombinant Protein Sales by Country (2025-2030) & (Kg)
Table 48. Middle East & Africa Prokaryotic Recombinant Protein Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Prokaryotic Recombinant Protein Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Prokaryotic Recombinant Protein Sales (Kg) by Type (2019-2024)
Table 51. Global Prokaryotic Recombinant Protein Sales (Kg) by Type (2025-2030)
Table 52. Global Prokaryotic Recombinant Protein Sales Market Share by Type (2019-2024)
Table 53. Global Prokaryotic Recombinant Protein Sales Market Share by Type (2025-2030)
Table 54. Global Prokaryotic Recombinant Protein Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Prokaryotic Recombinant Protein Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Prokaryotic Recombinant Protein Revenue Market Share by Type (2019-2024)
Table 57. Global Prokaryotic Recombinant Protein Revenue Market Share by Type (2025-2030)
Table 58. Global Prokaryotic Recombinant Protein Price (US$/Kg) by Type (2019-2024)
Table 59. Global Prokaryotic Recombinant Protein Price (US$/Kg) by Type (2025-2030)
Table 60. Global Prokaryotic Recombinant Protein Sales (Kg) by Application (2019-2024)
Table 61. Global Prokaryotic Recombinant Protein Sales (Kg) by Application (2025-2030)
Table 62. Global Prokaryotic Recombinant Protein Sales Market Share by Application (2019-2024)
Table 63. Global Prokaryotic Recombinant Protein Sales Market Share by Application (2025-2030)
Table 64. Global Prokaryotic Recombinant Protein Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Prokaryotic Recombinant Protein Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Prokaryotic Recombinant Protein Revenue Market Share by Application (2019-2024)
Table 67. Global Prokaryotic Recombinant Protein Revenue Market Share by Application (2025-2030)
Table 68. Global Prokaryotic Recombinant Protein Price (US$/Kg) by Application (2019-2024)
Table 69. Global Prokaryotic Recombinant Protein Price (US$/Kg) by Application (2025-2030)
Table 70. Eli Lilly and Company Corporation Information
Table 71. Eli Lilly and Company Description and Business Overview
Table 72. Eli Lilly and Company Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Eli Lilly and Company Prokaryotic Recombinant Protein Product
Table 74. Eli Lilly and Company Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Merck Prokaryotic Recombinant Protein Product
Table 79. Merck Recent Developments/Updates
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Roche Prokaryotic Recombinant Protein Product
Table 84. Roche Recent Developments/Updates
Table 85. Prospec-Tany Technogene Corporation Information
Table 86. Prospec-Tany Technogene Description and Business Overview
Table 87. Prospec-Tany Technogene Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Prospec-Tany Technogene Prokaryotic Recombinant Protein Product
Table 89. Prospec-Tany Technogene Recent Developments/Updates
Table 90. Cusabio Technology Corporation Information
Table 91. Cusabio Technology Description and Business Overview
Table 92. Cusabio Technology Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Cusabio Technology Prokaryotic Recombinant Protein Product
Table 94. Cusabio Technology Recent Developments/Updates
Table 95. Randox Laboratories Corporation Information
Table 96. Randox Laboratories Description and Business Overview
Table 97. Randox Laboratories Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Randox Laboratories Prokaryotic Recombinant Protein Product
Table 99. Randox Laboratories Recent Developments/Updates
Table 100. Batavia Biosciences Corporation Information
Table 101. Batavia Biosciences Description and Business Overview
Table 102. Batavia Biosciences Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Batavia Biosciences Prokaryotic Recombinant Protein Product
Table 104. Batavia Biosciences Recent Developments/Updates
Table 105. Geno Technology Corporation Information
Table 106. Geno Technology Description and Business Overview
Table 107. Geno Technology Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Geno Technology Prokaryotic Recombinant Protein Product
Table 109. Geno Technology Recent Developments/Updates
Table 110. Kaneka and Eurogentec Corporation Information
Table 111. Kaneka and Eurogentec Description and Business Overview
Table 112. Kaneka and Eurogentec Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Kaneka and Eurogentec Prokaryotic Recombinant Protein Product
Table 114. Kaneka and Eurogentec Recent Developments/Updates
Table 115. Abnova Corporation Corporation Information
Table 116. Abnova Corporation Description and Business Overview
Table 117. Abnova Corporation Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Abnova Corporation Prokaryotic Recombinant Protein Product
Table 119. Abnova Corporation Recent Developments/Updates
Table 120. Cayman Chemical Company Corporation Information
Table 121. Cayman Chemical Company Description and Business Overview
Table 122. Cayman Chemical Company Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Cayman Chemical Company Prokaryotic Recombinant Protein Product
Table 124. Cayman Chemical Company Recent Developments/Updates
Table 125. Geltor IndieBio Corporation Information
Table 126. Geltor IndieBio Description and Business Overview
Table 127. Geltor IndieBio Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Geltor IndieBio Prokaryotic Recombinant Protein Product
Table 129. Geltor IndieBio Recent Developments/Updates
Table 130. Bioclone Corporation Information
Table 131. Bioclone Description and Business Overview
Table 132. Bioclone Prokaryotic Recombinant Protein Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Bioclone Prokaryotic Recombinant Protein Product
Table 134. Bioclone Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Prokaryotic Recombinant Protein Distributors List
Table 138. Prokaryotic Recombinant Protein Customers List
Table 139. Prokaryotic Recombinant Protein Market Trends
Table 140. Prokaryotic Recombinant Protein Market Drivers
Table 141. Prokaryotic Recombinant Protein Market Challenges
Table 142. Prokaryotic Recombinant Protein Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prokaryotic Recombinant Protein
Figure 2. Global Prokaryotic Recombinant Protein Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Prokaryotic Recombinant Protein Market Share by Type in 2023 & 2030
Figure 4. Hormones Product Picture
Figure 5. Interferons Product Picture
Figure 6. Interleukins Product Picture
Figure 7. Others Product Picture
Figure 8. Global Prokaryotic Recombinant Protein Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Prokaryotic Recombinant Protein Market Share by Application in 2023 & 2030
Figure 10. Biotechnology Companies
Figure 11. Research institutes
Figure 12. Contract Research organizations
Figure 13. Hospital
Figure 14. Laboratories
Figure 15. Others
Figure 16. Global Prokaryotic Recombinant Protein Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Prokaryotic Recombinant Protein Market Size (2019-2030) & (US$ Million)
Figure 18. Global Prokaryotic Recombinant Protein Sales (2019-2030) & (Kg)
Figure 19. Global Prokaryotic Recombinant Protein Average Price (US$/Kg) & (2019-2030)
Figure 20. Prokaryotic Recombinant Protein Report Years Considered
Figure 21. Prokaryotic Recombinant Protein Sales Share by Manufacturers in 2023
Figure 22. Global Prokaryotic Recombinant Protein Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Prokaryotic Recombinant Protein Players: Market Share by Revenue in 2023
Figure 24. Prokaryotic Recombinant Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Prokaryotic Recombinant Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Prokaryotic Recombinant Protein Sales Market Share by Country (2019-2030)
Figure 27. North America Prokaryotic Recombinant Protein Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Prokaryotic Recombinant Protein Sales Market Share by Country (2019-2030)
Figure 31. Europe Prokaryotic Recombinant Protein Revenue Market Share by Country (2019-2030)
Figure 32. Germany Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Prokaryotic Recombinant Protein Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Prokaryotic Recombinant Protein Revenue Market Share by Region (2019-2030)
Figure 39. China Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Prokaryotic Recombinant Protein Sales Market Share by Country (2019-2030)
Figure 50. Latin America Prokaryotic Recombinant Protein Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Prokaryotic Recombinant Protein Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Prokaryotic Recombinant Protein Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. UAE Prokaryotic Recombinant Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Prokaryotic Recombinant Protein by Type (2019-2030)
Figure 60. Global Revenue Market Share of Prokaryotic Recombinant Protein by Type (2019-2030)
Figure 61. Global Prokaryotic Recombinant Protein Price (US$/Kg) by Type (2019-2030)
Figure 62. Global Sales Market Share of Prokaryotic Recombinant Protein by Application (2019-2030)
Figure 63. Global Revenue Market Share of Prokaryotic Recombinant Protein by Application (2019-2030)
Figure 64. Global Prokaryotic Recombinant Protein Price (US$/Kg) by Application (2019-2030)
Figure 65. Prokaryotic Recombinant Protein Value Chain
Figure 66. Prokaryotic Recombinant Protein Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
